News | June 06, 2026
Alembic Pharma receives USFDA approval for Haloperidol tablets
The approved product is therapeutically equivalent to Haldol tablets of Ortho McNeil Pharmaceutical
The approved product is therapeutically equivalent to Haldol tablets of Ortho McNeil Pharmaceutical
Approval for generic version of Xeljanz enables immediate launch and strengthens Aurobindo’s U.S. portfolio with its 586th ANDA approval
Multi-target licensing agreement combines Stipple Bio’s epitope discovery platform with Lonza’s ADC technologies to develop targeted cancer treatments
MSD joins as anchor customer as Aurobindo strengthens its position in the fast-growing global biologics manufacturing market
The drug currently approved for chronic kidney disease (CKD) associated with type 2 diabetes, may benefit a much broader group of patients than previously recognized
The robotic cardiac procedure between Guyana and India, established a new benchmark in global telesurgery across nearly 20,000 kilometres
Teva said the launch strengthens its biosimilars strategy and expands access to biologic medicines across Europe
Dr. Lall brings extensive experience in healthcare operations, business strategy, and hospital management
The industry is expected to grow significantly over the next few years as healthcare accessibility improves and insurance penetration increases
Regulatory clearance strengthens company’s global footprint and expands access to the Australian animal healthcare market
Subscribe To Our Newsletter & Stay Updated
